Ademi LLP Investigates Enhabit for Possible Fiduciary Breaches

Written by Emily J. Thompson, Senior Investment Analyst

Source: PRnewswire

Updated: 3 days ago

0mins

EHAB+0.15%

Should l Buy EHAB?

Source: PRnewswire

Transaction Investigation: Ademi LLP is investigating Enhabit for potential breaches of fiduciary duty in its transaction with Kinderhook Industries, which is valued at approximately $1.1 billion, offering shareholders $13.80 per share in cash.
Insider Benefits: Enhabit insiders are set to receive substantial benefits from the deal, which may influence the board's decisions and potentially compromise their fiduciary responsibilities to all shareholders.
Competition Restrictions: The transaction agreement imposes significant penalties on Enhabit for accepting competing bids, which could undermine the best interests of shareholders by limiting their options.
Board Conduct Review: We are examining the conduct of Enhabit's board of directors to determine whether they are fulfilling their fiduciary duties to all shareholders, ensuring that shareholder rights are protected.

Trade with 70% Backtested Accuracy

Stop guessing "Should I Buy EHAB?" and start using high-conviction signals backed by rigorous historical data.

Analyst Views on EHAB

Wall Street analysts forecast EHAB stock price to fall

5 Analyst Rating

4 Buy

1 Hold

0 Sell

Strong Buy

Current: 13.580

Low

10.50

Averages

12.20

High

14.00

Current: 13.580

Low

10.50

Averages

12.20

High

14.00

Jefferies

Buy

Hold

downgrade

2026-02-23

New

Reason

Jefferies

Price Target

AI Analysis

2026-02-23

New

downgrade

Buy

Hold

Reason

Jefferies downgraded Enhabit to Hold from Buy with a price target of $13.80, up from $12.50, following the company's agreement to be acquired by Kinderhook Industries in an all-cash transaction valued at $13.80 per share.

Oppenheimer

Perform

Outperform

upgrade

$14

2026-01-22

Reason

Oppenheimer

Price Target

$14

2026-01-22

upgrade

Perform

Outperform

Reason

Oppenheimer upgraded Enhabit to Outperform from Perform with a $14 price target. The firm believes the post-acute care group is benefiting from "major tailwinds," including strong demand, a more stable regulatory environment, and improving labor trends. Enhabit is positioned to benefit from an improved reimbursement outlook, the analyst tells investors in a research note. In addition, Oppenheimer says the company's operational initiatives should drive the business going forward.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for EHAB

Unlock Now

About EHAB

Enhabit, Inc. is a provider of home health and hospice services in the United States. Its segments include Home Health and Hospice. The Home Health segment provides a comprehensive range of Medicare-certified skilled home health services, including skilled nursing, physical, occupational and speech therapy, medical social work, and home health aide services. It works closely with patients, families, caregivers, and physicians to deliver data-driven, evidence-based care plans focused on patient needs and goals. Its home health services are provided by nurses, physical, occupational and speech therapists, medical social workers, and home health aides. The Hospice segment provides hospice services to terminally ill patients and their families. Hospice care focuses on the quality of life for patients experiencing an advanced, life- limiting illness by treating the symptoms of the disease, rather than the disease itself. It operates about 115 hospice agencies and 255 home health agencies.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

ENHABIT INC: UBS Increases Target Price from $12 to $13.8

2 days agomoomoo

UBS Raises Target Price: UBS has increased its target price for a specific asset from $12 to $13.8.
Market Implications: This adjustment reflects UBS's confidence in the asset's performance and potential growth in the market.

Investigation into Enhabit Acquisition Proposal

2 days agoBusinesswire

Acquisition Proposal Investigation: Former Louisiana Attorney General Charles C. Foti and his law firm Kahn Swick & Foti are investigating the proposed sale of Enhabit, Inc. (NYSE: EHAB) to Kinderhook Industries, aiming to assess the adequacy of the transaction.
Cash Acquisition Price: Under the proposal, Enhabit shareholders are set to receive $13.80 per share in cash, with the investigation focusing on whether this price adequately reflects the company's true value.
Legal Rights Consultation: KSF encourages shareholders who believe the transaction undervalues the company to reach out for legal consultation, emphasizing the importance of protecting shareholder rights and ensuring transparency in the transaction process.
Potential Impact Assessment: This investigation may affect shareholder confidence in Enhabit and market expectations regarding its future value, reflecting a cautious approach to the acquisition process that could lead to a reassessment of the transaction terms by shareholders.

Investor Rights Law Firm Investigates Multiple Companies

2 days agoPRnewswire

Investigation Focus: Halper Sadeh LLC is investigating Arcellx, Inc. (NASDAQ:ACLX) for potential fiduciary duty breaches related to its sale to Gilead Sciences, Inc. for $115.00 per share in cash plus a $5.00 contingent value right, which may disadvantage shareholders.
Shareholder Rights: Veris Residential, Inc. (NYSE:VRE) is being sold to an investor consortium led by Affinius Capital for $19.00 per share, and Halper Sadeh LLC encourages shareholders to contact them to understand their rights and options, potentially impacting financial outcomes.
Potential Compensation: United Homes Group, Inc. (NASDAQ:UHG) is selling to Stanley Martin Homes, LLC for $1.18 per share in cash, with Halper Sadeh LLC possibly seeking increased consideration and additional disclosures to protect shareholder interests.
Legal Support: Enhabit, Inc. (NYSE:EHAB) is being sold to Kinderhook Industries, LLC for $13.80 per share in cash, and Halper Sadeh LLC offers no-cost legal consultations to help shareholders address potential securities fraud and corporate misconduct issues.

Halper Sadeh Investigates Enhabit Acquisition by Kinderhook

3 days agoBusinesswire

Investigation Launched: Halper Sadeh LLC is investigating the acquisition of Enhabit, Inc. by Kinderhook Industries at a price of $13.80 per share, raising concerns about potential impacts on shareholder rights.
Legal Compliance Review: The investigation focuses on whether Enhabit and its board violated federal securities laws by failing to secure the best possible price for shareholders, potentially harming their interests.
Sales Process Transparency: Halper Sadeh highlights whether there were conflicts of interest in the sales process and if all material information was disclosed, which could affect shareholders' evaluation of the transaction.
Shareholder Rights Protection: The law firm may seek increased consideration, additional disclosures, or other relief on behalf of shareholders to safeguard their legal rights.